1163024AFFX
A leading provider of genetic analysis and microarray technology, this company develops and markets consumables, instruments, and software used in life sciences research, clinical diagnostics, and applied markets. Its products enable gene expression profiling, genotyping, and other genomic applications for academic, pharmaceutical, and clinical customers. Investors track the company for its role in advancing precision medicine and its exposure to the growing genomics market.
Congressional Interest in 1163024 (AFFX)
1 member of Congress has disclosed 8 trades in 1163024 (AFFX), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading AFFX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-02-07 | MICHAEL T. MCCAUL | sell | $15K-$50K |
| 2010-03-02 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2010-02-02 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2010-01-03 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2009-09-03 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2009-01-04 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2004-01-09 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2003-09-09 | MICHAEL T. MCCAUL | buy | $1K-$15K |